Susan R. Keyes - Concepedia

Concepedia

Author

Susan R. Keyes

Yale University

Also Known As

S R Keyes, Susan Keyes, Susan R. Keyes, Susan Riley Keyes

17

Publications

1.4K

Citations

12

H-Index

51

Concepts

All Affiliations

Yale University University of Illinois Urbana-Champaign Yale Cancer Center

SR

About

Susan R. Keyes is an author at Yale University specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.3K
2	Education	2	2	763
3	Natural Sciences	2	2	195
4	Engineering	1	1	57
5	Behavioral Sciences	1	1	427

Susan R. Keyes

×

12

Publications

1.4K

Citations

12

H-Index

	Year	Citations
Longitudinally Foretelling Drug Usage in Adolescence: Early Childhood Personality and Environmental Precursors Jack Block, Jeanne H. Block, Susan R. Keyes Child Development Substance UseEarly AdolescenceEducationAdolescenceDrug Usage	1988	427
Longitudinally Foretelling Drug Usage in Adolescence: Early Childhood Personality and Environmental Precursors Jack Block, Jeanne H. Block, Susan R. Keyes Child Development Substance AbuseSubstance UseEarly Childhood PersonalityPsychiatryEnvironmental Precursors	1988	336
Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1. Susan R. Keyes, Paula M. Fracasso, David Heimbrook, PubMed Chemoprevention StrategyMitomycin C1Molecular BiologyHypoxic CellsChemical Biology	1984	177
Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro. Susan R. Keyes, Sara Rockwell, Alan C. Sartorelli PubMed Emt6 Tumor-bearing AnimalsMitomycin CMedicinePharmacologyImmunology	1985	71
Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro. Susan R. Keyes, Sara Rockwell, Alan C. Sartorelli PubMed Hypoxic CellsTumor BiologyRadiation MedicineCancer Cell BiologySelective Toxicity	1985	64
Preclinical studies of porfiromycin as an adjunct to radiotherapy. Sara Rockwell, Susan R. Keyes, Alan C. Sartorelli PubMed EngineeringMitomycin CRadiation EffectPharmacotherapySolid Emt6 Tumors	1988	57
Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin C Susan R. Keyes, David Heimbrook, Paula M. Fracasso, Advances in Enzyme Regulation Tumor BiologyOncologyMedicineChemotherapeutic AttackAnti-cancer Agent	1985	54
Reversal of in vivo drug resistance by the transforming growth factor-β inhibitor decorin Beverly A. Teicher, Yoshihiko Maehara, Yoshihiro Kakeh, International Journal of Cancer	1997	50
Enhancement of anthracycline growth inhibition in parent and multidrug-resistant Chinese hamster ovary cells by cyclosporin A and its analogues. Setsuko K. Chambers, William N. Hait, Barry M. Kacinski, PubMed Molecular PharmacologyMedicinal ChemistryMedicineImmunologyGrowth Inhibition	1989	49
Preclinical Studies of Porfiromycin as an Adjunct to Radiotherapy Sara Rockwell, Susan R. Keyes, Alan C. Sartorelli Radiation Research Radiation MedicineRadiation TherapyMedicinePreclinical StudiesPharmacotherapy	1988	45

Page 1